The Dalbavancin Market depends on pharmaceutical manufacturing capabilities and reliable distribution of injectable antibiotic products. Maintaining product quality, sterile manufacturing standards, and consistent supply is essential for healthcare providers that use the medicine. The Dalbavancin Market size is expected to reach US$ 1,216.61 million by 2034 from US$ 615.05 million in 2025,...